The Augmentation Review Grinds On as Roughly One in Twenty Live Enhanced

BRUSSELS — Roughly one in twenty people now live with some neural or somatic augmentation, and the safety review that shadows the industry remains, as it has all year, open and unresolved. The regulatory inquiry into neural-interface implants — the one that keeps the manufacturers from calling their devices cleared — took no decisive turn this week, and that non-event is itself the story for the augmented workers whose livelihoods hang on its outcome. "Every month it stays open is a month I plan nothing," said Lena Fischer, a logistics coordinator in Brussels whose interface lets her manage warehouse flows no unaugmented colleague could match. Somaform Augmetics, whose founder Julian Morrow argues the review is thorough to a fault, has kept its neural line on the market pending the verdict. The inquiry examines whether the interfaces are as safe as sold; no finding has been issued, and none is promised. For the roughly five percent living enhanced, the contest is not abstract — it is the question of whether the thing already wired into them will still be permitted tomorrow.